Florian Bassermann

6.1k total citations
105 papers, 2.9k citations indexed

About

Florian Bassermann is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Florian Bassermann has authored 105 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 42 papers in Hematology and 39 papers in Oncology. Recurrent topics in Florian Bassermann's work include Multiple Myeloma Research and Treatments (22 papers), Ubiquitin and proteasome pathways (19 papers) and Protein Degradation and Inhibitors (14 papers). Florian Bassermann is often cited by papers focused on Multiple Myeloma Research and Treatments (22 papers), Ubiquitin and proteasome pathways (19 papers) and Protein Degradation and Inhibitors (14 papers). Florian Bassermann collaborates with scholars based in Germany, United States and Austria. Florian Bassermann's co-authors include Michele Pagano, Daniele Guardavaccaro, Luca Busino, David Frescas, Ruth Eichner, Angelo Peschiaroli, Patrick M. Nolan, Alessio Maiolica, Sofia I.H. Godinho and Choogon Lee and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Florian Bassermann

98 papers receiving 2.9k citations

Peers

Countries citing papers authored by Florian Bassermann

Since Specialization

Citations

This map shows the geographic impact of Florian Bassermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Bassermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Bassermann more than expected).

Fields of papers citing papers by Florian Bassermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Bassermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Bassermann. The network helps show where Florian Bassermann may publish in the future.

Co-authorship network of co-authors of Florian Bassermann

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Bassermann. A scholar is included among the top collaborators of Florian Bassermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Bassermann. Florian Bassermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting Intracellular Innate RNA-Sensing Systems Overcomes Resistance to CAR T-cell Therapy in Solid Tumors 2025 ·Cancer Research ·(unknown), Tatiana Nedelko, (unknown), (unknown), Vincent Grass, Julius Fischer, Florian Bassermann, Hendrik Poeck, Sebastian Kobold, (unknown), Simon Heidegger	1
2	Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells 2025 ·Theranostics ·(unknown), Min Yu, (unknown), Mark van der Garde, Sukhen C. Ghosh, Laura M. Bartos, Matthias Brendel, Florian Bassermann, Ali Azhdarinia, Wolfgang Weber, Katharina S. Götze, Susanne Kossatz	0
3	Label-free protein-structure-sensitive live-cell microscopy for patient-specific assessment of myeloma therapy 2025 ·Nature Biomedical Engineering ·(unknown), (unknown), (unknown), (unknown), (unknown), Andriy Chmyrov, (unknown), Dominik Jüstel, Florian Bassermann, Vasilis Ntziachristos, Miguel A. Pleitez	0
4	Proteomic analyses identify targets, pathways, and cellular consequences of oncogenic KRAS signaling 2025 ·Science Signaling ·(unknown), Florian Bayer, (unknown), Miriam Abele, Amirhossein Sakhteman, Yun-Chien Chang, (unknown), (unknown), (unknown), Maria Reinecke, (unknown), (unknown), Matthew The, Hannes Hahne, Florian Bassermann, Christina Ludwig, Paola Vagnarelli, Bernhard Küster	2
5	Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response 2024 ·Vaccines ·(unknown), Samuel Jeske, (unknown), (unknown), (unknown), (unknown), Lutz Renders, Ulrike Protzer, Katharina S. Götze, Peter Herhaus, Mareike Verbeek, Christoph D. Spinner, Florian Bassermann, (unknown), Bernhard Haller, Jochen Schneider, Michael Heider	0
6	CXCR4-directed endoradiotherapy with [¹⁷⁷Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia 2024 ·Theranostics ·(unknown), (unknown), (unknown), Katrin Koch, (unknown), Jan C. Peeken, Katharina S. Götze, Wolfgang Weber, (unknown), Calogero D’Alessandria, Julia Brosch-Lenz, Florian Bassermann, Martina Rudelius, Mareike Verbeek, Matthias Eiber, Peter Herhaus	2
7	Regulation of BCMA By the Ubiquitin Proteasome System Enables Optimization of BCMA-Targeting Therapies in Multiple Myeloma 2023 ·Blood ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tobias Schulze, Piero Giansanti, Lenka Bešše, Christoph Driessen, Angela M. Krackhardt, Bernhard Küster, Florian Bassermann	3
8	sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study 2022 ·Blood Advances ·(unknown), (unknown), Hans‐Joachim Stemmler, Fabian Hauck, Hendrik Schulze‐Koops, Stephanie-Susanne Stecher, Michael Starck, Clemens‐Martin Wendtner, Peter Bojko, Marcus Hentrich, (unknown), Katharina S. Götze, Florian Bassermann, Michael von Bergwelt‐Baildon, Karsten Spiekermann	11
9	Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma 2022 ·EJNMMI Research ·Volker Morath, Michael Heider, (unknown), (unknown), (unknown), Jérémie Calais, Matthias Eiber, Florian Bassermann, Wolfgang Weber	4
10	Comparative analysis of extracellular vesicle isolation methods from human AML bone marrow cells and AML cell lines 2022 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Oumaima Stambouli, (unknown), (unknown), Hendrik Dietz, Bernd Giebel, Florian Bassermann, Robert A.J. Oostendorp, Katharina S. Götze, Judith S. Hecker	19
11	Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma 2021 ·European Journal Of Haematology ·Christian Straka, Hans Salwender, Stefan Knop, Martin Vogel, (unknown), Bernd Metzner, Christian Langer, Herbert G. Sayer, Wolfram Jung, Heinz Dürk, Florian Bassermann, Martin Gramatzki, Wolf Rösler, Hans‐Heinrich Wolf, Wolfram Brugger, Monika Engelhardt, Thomas Fischer, Peter Liebisch, Hermann Einsele	4
12	MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma 2021 ·Blood Advances ·(unknown), Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, (unknown), Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Christof Scheid, Ulrich Keller, Dirk Hose, Florian Bassermann	7
13	IFN-Gamma Producing Regulatory T Cells Counterbalance T Cell-Mediated Injury to the Intestinal Stem Cell Compartment in Mice and Humans 2021 ·Blood ·(unknown), Julius Fischer, (unknown), Erik Thiele Orberg, Dirk H. Busch, Sebastian Jarosch, Ernst Holler, Thomas Engleitner, (unknown), (unknown), (unknown), (unknown), (unknown), Katja Steiger, Roland Rad, (unknown), Florian Bassermann, Simon Heidegger, Hendrik Poeck	1
14	MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF 2021 ·Cell Death and Differentiation ·Xin Wang, Uris Ros, (unknown), (unknown), Julia Slotta‐Huspenina, Veronika Dill, Bo Shen, Run Shi, Tobias Herold, Claus Belka, Ritu Mishra, Florian Bassermann, Ana J. García‐Sáez, Philipp J. Jost	12
15	RIG-I activation is critical for responsiveness to checkpoint blockade 2019 ·Science Immunology ·Simon Heidegger, Alexander Wintges, (unknown), Sarah Bek, Katja Steiger, Paul-Albert Koenig, (unknown), Thomas Engleitner, Rupert Öllinger, Tatiana Nedelko, Julius Fischer, Vladimir Makarov, Christof Winter, Roland Rad, Marcel R.M. van den Brink, Jürgen Ruland, Florian Bassermann, Timothy A. Chan, Tobias Haas, Hendrik Poeck	96
16	Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection 2019 ·Life Science Alliance ·Julian J. Albers, Tim Ammon, (unknown), Stefan Audehm, Silvia Thoene, Christof Winter, (unknown), Anja Wolf, Anja Stelzl, Katja Steiger, Jürgen Ruland, Florian Bassermann, Christian Kupatt, Martina Anton, Angela M. Krackhardt	19
17	The Cdc14B-Cdh1-Plk1 Axis Controls the G2 DNA-Damage-Response Checkpoint 2008 ·Cell ·Florian Bassermann, David Frescas, Daniele Guardavaccaro, Luca Busino, Angelo Peschiaroli, Michele Pagano	325
18	SCF ^Fbxl3 Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins 2007 ·Science ·Luca Busino, Florian Bassermann, Alessio Maiolica, Choogon Lee, Patrick M. Nolan, Sofia I.H. Godinho, Giulio Draetta, Michele Pagano	415
19	NIPA Defines an SCF-Type Mammalian E3 Ligase that Regulates Mitotic Entry 2005 ·Cell ·Florian Bassermann, Christine von Klitzing, (unknown), Ren-Yuan Bai, Hiroyuki Kawaguchi, Stephan W. Morris, Christian Peschel, Justus Duyster	61
20	Phosphorylation of Grb10 Regulates Its Interaction with 14-3-3 2005 ·Journal of Biological Chemistry ·(unknown), Florian Bassermann, Ren-Yuan Bai, (unknown), Christian Peschel, Justus Duyster	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact